Kathryn E. Luker

Dr. Kathryn E. Luker


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JSJonathan W. Song
Jonathan W. Song
SCStephen P. Cavnar
Stephen P. Cavnar
AWAnn C. Walker
Ann C. Walker
KLKathryn E. Luker
Kathryn E. Luker
MGMudit Gupta
Mudit Gupta
STShuichi Takayama
Shuichi Takayama
The ability to properly model intravascular steps in metastasis is essential in identifying key physical, cellular, and molecular determinants that can be targeted therapeutically to prevent metastatic disease. Research on the vascular microenvironment has been hindered by challenges in studying this compartment in metastasis under conditions that reproduce in vivo physiology while allowing facile experimental manipulation. We present a microfluidic vasculature system to model interactions between circulating breast cancer cells with microvascular endothelium at potential sites of metastasis. The microfluidic vasculature produces spatially-restricted stimulation from the basal side of the endothelium that models both organ-specific localization and polarization of chemokines and many other signaling molecules under variable flow conditions. We used this microfluidic system to produce site-specific stimulation of microvascular endothelium with CXCL12, a chemokine strongly implicated in metastasis. When added from the basal side, CXCL12 acts through receptor CXCR4 on endothelium to promote adhesion of circulating breast cancer cells, independent of CXCL12 receptors CXCR4 or CXCR7 on tumor cells. These studies suggest that targeting CXCL12-CXCR4 signaling in endothelium may limit metastases in breast and other cancers and highlight the unique capabilities of our microfluidic device to advance studies of the intravascular microenvironment in metastasis.

1 July 2006 in Cancer Letters
Verified
Journal Article
Closed access
KLKathryn E. Luker
Kathryn E. Luker
GLGary D. Luker
Gary D. Luker

5 September 2010 in Nature Methods
Verified
Journal Article
Closed access
PDF file
DSDmitry Shcherbo
Dmitry Shcherbo
ISIrina I Shemiakina
Irina I Shemiakina
ARAnastasiya V Ryabova
Anastasiya V Ryabova
KLKathryn E. Luker
Kathryn E. Luker
BSBradley T Schmidt
Bradley T Schmidt
DCDmitriy M Chudakov
Dmitriy M Chudakov

22 June 2003 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
GLGary D Luker
Gary D Luker
CPChristina M Pica
Christina M Pica
JSJiling Song
Jiling Song
KLKathryn E. Luker
Kathryn E. Luker
DPDavid Piwnica-Worms
David Piwnica-Worms


1 October 2005 in Virology
Verified
Journal Article
Closed access
KLKathryn E. Luker
Kathryn E. Luker
MHMartha Hutchens
Martha Hutchens
TSTracey Schultz
Tracey Schultz
Andrew PekoszAndrew Pekosz
Andrew Pekosz
GLGary D. Luker
Gary D. Luker